SCHEMBL9300682

SCHEMBL9300682

CC(C)(C)C1(O)CCN(C(P(=O)(O)O)P(=O)(O)O)CC1

nearest known ligand 0.48

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FDPS P14324 3/20 0.48
OPRM1 P35372 1/20 0.46
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
OPRL1 P41146 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9303011 0.79 FDPS (0.54) FDPS
SCHEMBL9302739 0.76 FDPS (0.56) FDPS
SCHEMBL9302962 0.76 FDPS (0.50) FDPSOPRM1OPRD1OPRK1OPRL1
SCHEMBL9302434 0.74 FDPS (0.48) FDPSOPRM1OPRD1OPRK1OPRL1
SCHEMBL16117667 0.74 OPRM1 (0.53) OPRM1OPRD1OPRK1OPRL1
SCHEMBL9301189 0.74 FDPS (0.58) FDPS
SCHEMBL9301634 0.73 FDPS (0.52) FDPS
SCHEMBL9300740 0.73 FDPS (0.52) FDPS
SCHEMBL9301246 0.72 FDPS (0.56) FDPS
SCHEMBL898693 0.72 FDPS (0.75) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350743-A Treatment of osteoporosis KAKEN PHARMACEUTICAL CO., LTD. (JP) 1994-09-27 US disclosed
EP-0498424-A1 Bisphosphonic acid derivatives and bone resorption inhibitors containing them Kaken Pharmaceutical Co., Ltd. (JP) 1992-08-12 EP disclosed